Picture of Willis Towers Watson logo

WTW Willis Towers Watson News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsConservativeLarge CapNeutral

WTW Q4 revenue falls 3% but beats estimates

Overview

Advisory firm's Q4 revenue fell 3% yr/yr but beat analyst expectations

Adjusted EPS for Q4 was $8.12, beating analyst expectations

Company repurchased $350 mln in shares during the quarter

Outlook

WTW expects 2026 adjusted operating margin expansion in R&B and HWC segments

Company plans share repurchases of $1.0 bln or greater in 2026

WTW anticipates foreign currency tailwind on EPS of ~$0.30 in 2026

Result Drivers

TRANZACT SALE - Revenue decreased 3% due to the sale of TRANZACT, impacting overall results

ORGANIC GROWTH - Organic revenue grew 6% in Q4, driven by strong client retention and new client wins

RISK & BROKING GROWTH - Revenue in Risk & Broking segment increased 10% due to higher new business activity and client retention

Key Details

MetricBeat/MissActualConsensus Estimate
Q4 RevenueBeat$2.94 bln$2.87 bln (13 Analysts)
Q4 Adjusted EPSBeat$8.12$7.94 (19 Analysts)
Q4 EPS$7.62
Q4 Adjusted Operating Margin36.90%
Q4 Operating Margin34.60%
Q4 Organic Growth6.00%
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy", 7 "hold" and 1 "sell" or "strong sell" The average consensus recommendation for the multiline insurance & brokers peer group is "hold." Wall Street's median 12-month price target for Willis Towers Watson PLC is $371.00, about 17.2% above its February 2 closing price of $316.61 The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 17 three months ago Press Release: ID:nGNX2NxfT3 For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Willis Towers Watson

See all news